BEGIN:VCALENDAR VERSION:2.0 PRODID:icalendar-ruby CALSCALE:GREGORIAN BEGIN:VEVENT DTSTAMP:20240329T125435Z UID:5db8451d-8383-4081-b517-558d199a8402 DTSTART:20210318T080000 DTEND:20210319T080000 CLASS:PRIVATE DESCRIPTION:
About
\n\nSTD CONFERENCE 2021 Dear Attendees\, Conference Series LL C Ltd proudly announces 7th International Conference on HIV/AIDS\, STDs an d STIs in March 18-19\, 2021 at New York USA. This Conference focus on HIV Science features the latest HIV science\, including basic\, clinical and prevention research. It brings together top basic\, translational\, and cl inical researchers from around the world to share the latest studies\, imp ortant developments\, and best research methods in the ongoing battle agai nst HIV/AIDS and related infectious diseases. The primary goals of this ac tivity are to increase each participant'\;s competence to: Summarize cu rrent approaches to achieving a cure for HIV infection Identify the optima l antiretroviral management options for patients with HIV and newer therap ies in development Illustrate advances in the approach to prevention of HI V infection Recognize factors important for assessing risk for cardiovascu lar disease and options for preventing cardiovascular morbidities Demonstr ate the opportunities and challenges of treating addicted patients Detail the current treatment options for management of patients with HBV or HCV a nd newer therapies now in development Explain how to recognize\, avoid and manage drug-drug interactions Describe developments and controversies in HCV-infected organ transplantation Identifying optimal antiretroviral ther apy (ART)\, treatment initiation\, salvage therapy\, and pre- and post-exp osure prophylaxis and adherence to lifelong therapies Major Scientific Ses sions: AIDS stigma and discrimination HIV and bone damage Viral\, Bacteria l\, Fungal &\; Protozoan STDs HIV and aging HIV and AIDS Nursing Care M anagement HIV in women HIV and Retroviral Diseases Affecting Afro-Asian Co ntinents Global Epidemiology of HIV/AIDS\, STDs\, &\; STIs HIV Drug Dis covery and Research HIV Diagnosis and Therapy Venereal Diseases Prevention and Treatment Emerging Technologies towards HIV/AIDS HIV and cardiovascul ar disease HIV/AIDS Related CANCER Market Anlaysis HIV in fection and AIDS have become a major worldwide public health problem. Acco rding to WHO approximately 35 million people worldwide living with HIV/AID S in 2013\, unaware of the outcomes. AIDS (acquired immunodeficiency syndr ome) is a chronic\, potentially life-threatening condition caused by the h uman immunodeficiency virus (HIV) which damages the immune system and\, in terferes with body'\;s ability to fight the organisms that cause diseas e. HIV is Sexually transmitted diseases which spread by contact with infec ted blood or from mother to child transmission during pregnancy\, childbir th or breast-feeding. It can take years before HIV weakens the immune syst em to the point that the person is infected with AIDS. With the generous r esponse and support received from the participants of HIV/AIDS\, STDs\, &a mp\; STIs International Conference. Conference Series proudly announces 7t h International Conference on HIV/AIDS\, STDs and STIs. (STD Conference 20 21) which is slated at March 18-19th New York\, USA. The theme of the conf erence is &ldquo\;Current approaches to achieving a cure for HIV infection &rdquo\;. Conference Series Organizes 300 Conferences every year across US A\, Europe &\; Asia with support from 1000 more scientific societies an d Publishes 400 Open access journals which contains over 30000 eminent per sonalities\, reputed scientists as editorial board members. Infection rate s are high in San Francisco and metro Cities. CA ranked 4th in the number of new AIDS cases\, 7th in cumulative AIDS cases and 8th in the number of persons living with AIDS in 50 states\, Miami show more than 26\,000 peopl e living with HIV/AIDS\, and more than 9\,500 of these (37%) have diagnose d AIDS cases. Approximately in World 123235 members are associated to HIV/ AIDS\, 56657 countries wise\, 80 city wise. Global HIV/AIDS market\, inclu ding branded products and generics\, was valued at $11.3 billion in 2010. $11.8 billion in 2011 and increase at a 4.6% compound annual growth rate ( CAGR) over the 2011-2021 forecast periods to reach $14.1 billion in 2021. Branded products to treat HIV/AIDS were worth nearly $10.7 billion in 2010 and should reach $11 billion in 2011. This sector is expected to reach $1 3.2 billion in 2021.For more From the beginning of the epidemic\, almost 7 5 million people have been infected with the HIV virus and about 36 millio n people have died of HIV. Globally\, 35.3 million [32.2&ndash\;38.8 milli on] people were living with HIV at the end of 2012. An estimated 0.8% of a dults aged 15&ndash\;49 years worldwide are living with HIV\, although the burden of the epidemic continues to vary considerably between countries a nd regions. Sub-Saharan Africa remains most severely affected\, with nearl y 1 in every 20 adults living with HIV and accounting for 71% of the peopl e living with HIV worldwide. Since the height of the epidemic in the mid-1 980s\, the annual number of new HIV infections in the United States has be en reduced by more than two-thirds\, from roughly 130\,000 to 50\,000 annu ally. Atlanta finds itself the number five ranked city when it comes to ne w diagnoses of HIV &mdash\; a statistic that is rooted in HIV testing not being offered in places where most people get access to health care. Grady Hospital is the only emergency department in Atlanta that offers an HIV t est to every patient regardless of why they are in need of care. Various u niversities and research institutes like EMORY university\, CDC Atlanta et c performs various research based on HIV/AIDS.
\n\nAGENDA 20
21 ------------------------------------
2021 Upcoming Soon ------------------------------------
strong> Day 1 October 29\, 2021 Conference Hall:
Plaza II 08:00-08:45 Registrations 08:45-09:00 Opening Ceremony K
eynote Forum 09:00-09:40 Title: T-patterns and self-similarity from protei
n to cell to human mass-societies Magnus S Magnusson\, University of Icela
nd\, Iceland 09:40-10:20 Title: Progress toward curing HIV with cord blood
transplantation Lawrence Petz\, StemCyte Inc.\, USA Panel Discussion &
\; Group Photo 10:20-10:30 Networking &\; Refreshment Break 10:30-10:50
@ Plaza Foyer 10:50-11:30 Title: Placental umbilical cord whole blood tra
nsfusion in emergency when the haemoglobin concentration is less than 8gm
percent in paediatric to geriatric age group from 1999 Niranjan Bhattachar
ya\, Calcutta School of Tropical Medicine\, India 11:30-12:10 Title: The e
fficacy of trauma-informed and structurally-competent models of HIV testin
g and treatment by healthcare centers in addressing stigma and health disp
arites within marginalized communities Chiara Pride\, Trinity University\,
USA 12:10 -12:50 Title: Ethics of human fetal tissue transplant: Some obs
ervations Sanjukta Bhattacharya\, Jadavpore University\, India Lunch Break
12:50-13:50 @ Plaza Foyer Sessions: Hematology| Blood Disorders| Hemato-O
ncology |Awareness and Knowledge on HIV/AIDS\, STDs and STIs|Paediatric He
matology| Blood Banking |Hematology Nursing| Viral Immunology and Vaccines
Development Session Chair: Lawrence Petz\, StemCyte Inc.\, USA Session In
toduction 13:50-14:20 Title: Move forward to blood safety in Blood Transfu
sion Centre Jongkol Akahat\, Khon Kaen University\, Thailand 14:20-14:50 T
itle: T-ACE II+ : Semi-automated in blood components preparation Thipaporn
Jaroonsirimaneekul\, Khon Kaen University\, Thailand 14:50-15:20 Title: E
ffectiveness of classroom based HIV and AIDS education among in-school ado
lescents in Orlu senatorial zone\, Imo state\, Nigeria Martina Ezeama\, Im
o State University\, Nigeria 15:20-15:50 Title: Breast cancer resistance p
rotein (BCRP) in acute myeloid leukemia: Clinical relevance and prognostic
significance. Heba Gouda\, Cairo University\, School of Medicine\, Egypt
Panel Discussions Networking &\; Refreshment Break 15:50-16:10 @ Plaza
Foyer 16:10-16:40 Title: Beyond the legislation for sickle cell prevention
&ndash\; Getting the right outcomes. A Nigerian Experience Ogbonna Collin
s Nwabuko\, Federal Medical Center\, Nigeria 16:40-17:10 Title: B cell exh
austion in HIV: A role for programmed death receptor 1 (PD-1) immune check
point Jacobus Hendricks\, University of KwaZulu-Natal\, South Africa 17:10
-17:40 Title: Garbage to gold- Experience of placental umbilical cord whol
e blood transfusion in Eastern India Amitabha Bhattacharya\, Calcutta Scho
ol of Tropical Medicine\, India 17:40-18:10 Title: Genetic variations in t
umor necrosis factor related apoptosis-inducing ligand-1 and the susceptib
ility to B cell Non-Hodgkin lymphoma in Egypt Mervat Khorshied\, Kasr Al A
iny School of Medicine\, Cairo\, Egypt 18:10- 18:30 Title: Acute transient
myopericarditis with left ventricular dysfunction as a rare manifestation
of differentiation syndrome (ATRA syndrome) in a case of pediatric acute
promyelocytic leukemia Rubiya Nadaf\, Healthcare Global\, India Panel Diss
cussion &\; Award Ceremony Day 2 October 30\, 2021
Please contact t he event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for : - Multiple participant discounts - Price quotations or visa invitation l etters - Payment by alternate channels (PayPal\, check\, Western Union\, w ire transfers etc) - Event sponsorship NO REFUNDS ALLOWED ON REGISTRATIONS Prices may go up any time. Service fees included in pricing. ------------ ----------------------------------------------------- This event is brough t to you by: Conference Series - NewYorkEventsList http://www.NyEventsList .com http://www.BostonEventsList.com http://www.SFBayEventsList.com ------ -----------------------------------------------------------
\n\nVIO181212CRE
\n SUMMARY:7th International Conference on HIV/AIDS\, STDs and STIs (CSE) S BEGIN:VALARM ACTION:DISPLAY TRIGGER:-PT1H SUMMARY:7th International Conference on HIV/AIDS\, STDs and STIs (CSE) S END:VALARM END:VEVENT END:VCALENDAR